Aim of the study: To study changes in pulmonary function tests after esophageal variceal injection sclerotherapy in comparison to changes after esophageal variceal band ligation.
Introduction
Esophageal varices are extremely dilated sub-mucosal veins in the lower third of the esophagus [1] . They are most often a consequence of portal hypertension, commonly due to cirrhosis and one of the common causes of upper gastrointestinal bleeding. Diagnosis of variceal bleeding or risk of bleeding is done by upper gastrointestinal endoscopy [2] . Variceal bleeding is a major complication of portal hypertension and represents a leading cause of death in patients with cirrhosis. Diagnostic and therapeutic developments have led to a significant improvement in the prognosis of variceal bleeding [3] .
Endoscopic therapies for varices aim to reduce variceal wall tension by obliteration of the varix. The two principal methods available for esophageal varices endoscopic therapy are endoscopic sclerotherapy (EST) and endoscopic band ligation (EBL). Endoscopic therapy is a local treatment that has no effect on the pathophysiological mechanisms that lead to portal hypertension and variceal rupture. However, a spontaneous decrease in hepatic venous pressure gradient occurs in around 30% of patients treated with either EST or EBL to prevent variceal rebleeding [4] .
The complications of injection sclerotherapy have been extensively reviewed [5] .They can be divided broadly into two categories, those occurring at the site of injection and those resulting from systemic dissemination of the sclerosant through the paraoesophageal and azygos veins; this has been shown radiologically [6] . Abnormalities of organ function have been described including abnormal chest radiology [7] , and rarely respiratory failure 
Discussion
Sclerotherapy has proven to be inferior to band ligation for primary and secondary prophylaxes of variceal hemorrhage, due to a higher number of complications, and the fact that more sessions are required to achieve variceal obliteration [15]. However, ESC has still been found to be similar to EBL for control of bleeding in some studies [16] .
This study was performed to compare between effect of injection sclerotherapy of esophageal varices and band ligation on pulmonary functions. The study was performed on 30 patients with hepatic cirrhosis & portal hypertension and classified into 2 groups: Group I:15 patients scheduled to have elective sclerotherapy of their esophageal varices Group II:15 patients scheduled to have band ligation of their esophageal varices .
The demographic data of the studied subjects included in this study are illustrated in who studied pulmonary function tests in 12 patients received injection sclerotherapy by using ethanol amine oleate under general anesthesia in comparison to 9 subjects had only esophagoscpy under general anesthesia.They did pulmonary function test one day after procedure to be sure of elimination of possible effect of anesthesia or sedation on pulmonary function . They found that, the vital capacity decreased by 0.39 liter ( p ˂ 0.05) in patients who received injection sclerotherapy but did not change in non injected group. PaO2 in injected group was 94.8 mm Hg then decreased by 9.3 mmHg after one day from injection ( p ˂ 0.05) .while in non injected group before endoscopy was 93.8 mmHg and after endoscopy was 93.8 mmHg. This study also revealed no significant changes in FVC,FEV1/FVC and PaCO2 in group I and group II before and after procedures . Also our results are in agreement with the study done by Pradeepta et al., [18] where they studied twenty-six patients with portal hypertension of different etiologies. Patients were subjected to variceal sclerotherapy using absolute alcohol, they found significant decline in FVC, FEV1 after sclerotherapy as compared with baseline values however FEV1/FVC ratio did not change significantly.
These changes in respiratory function could be explained by, embolisation of sclerosant to the lung, but other possibilities include intravascular platelet aggregation is postulated [19]. Another explanation for the decrease in PaO2 could be the severity of the cirrhosis. Porto-systemic shunting of blood occurs in decompensated cirrhosis and this results in the delivery of endotoxins directly from the gut to the systemic circulation. This can affect platelet aggregation mechanisms, coagulation, and ultimately pulmonary functions [20] .
The present study revealed significant linear correlation between the decreases in PaO2 and the percentage decrease in vital capacity( p ˂ 0.05) figure(1) . These results are in agreement with the study done by Samuli et al. [17] .The close correlation between the decrease in PaO2 and the fall in vital capacity suggest that a decrease in lung volume was the probable cause of the drop in PaO2 described here and resulting perhaps from a decrease in compliance. The most probable explanation would be sclerosant embolisation by the paraoesophageal and azygos veins to the lung resulting in areas of alveolar exudate and consolidation with increase in lung stiffness and pulmonary shunt. There is evidence that sclerosant dissemination to the pulmonary and systemic circulation after intravariceal sclerotherapy occurs through esophagogastric collaterals and the azygoushemiazygous systems [19] .Entry of sclerosant into the pulmonary circulation has been demonstrated to occur by positive uptake on lung scan of technetium-99m (Tc99m)-tagged sodium morrhuate (SM) and sodium tetradecyl sulfate(STS) solutions when injected into esophageal varices [6] . The comparison of pulmonary functions in group I before& after one week from injection sclerotherapy-in the same arrangement-in table (3) were VC =4.24 ±0.39 liters before and 4.05 ±0.48 liters one week after therapy (P > 0.05). FEV1 =3.6± 0.33 liters before and 3.44± 0.30 liters one week after therapy (P >0.05). FVC= 4.4 ± 0.37 liters before and 4.5 ± 0.39 one week after therapy (P > 0.05). FEV1/FVC% =76.35±4.2 before and 77.35±4.3 one week after therapy (P >0.05). PaO2 = 94.1±2.12 mm Hg before and 93.1±1.98 mm Hg one week after therapy (P >0.05). PaCO2 = 40.1±2.64 mm Hg before and 40.3±2.34 one week after therapy (P >0.05). These results revealed improvement of pulmonary function and returning to the basal level after one week from sclerotherapy. These findings could be explained by that ,the deleterious effect of sclerotherapy on pulmonary functions are transient and reversible [7] . Conclusion Patients undergoing elective esophageal injection sclerotherapy develop a restrictive defect (decrease in PaO2 and vital capacity) in pulmonary function one day after the procedure; these decreases are transient and subside within one week. On the other hand no effect for esophageal band ligation on respiratory function test.
Results
We included in this study 30 patients with age ranging from 41 to 63 years. Table 1 showed that there was no significant difference between patients treated with injection sclerotherapy and those treated with band ligation regarding baseline demographic factors or stage of cirrhosis. Comparison of pulmonary functions preprocedure and one day after the procedure in both groups showed that VC, FEV1, and PaO2 has been significantly decreased after injection sclerotherapy but not affected with band ligation (Table 2) . We found also a significant positive correlation between changes in vital capacity and changes in PaO2 (Fig.1) .
Follow up pulmonary functions tests after one week of the procedures showed that VC, FEV1, and PaO2 that has been decreased one day after procedure have returned back to baseline (Table 4) . 
